Renal cell carcinoma (RCC) with inferior vena cava (IVC) tumor thrombus (IVCTT) occurs in 4 to 10 percent of locally advanced RCC cases and represents one of the most technically demanding surgical scenarios in urological oncology. The tumor thrombus extends from the renal vein into the IVC and can propagate to or above the liver, requiring meticulous vascular control to avoid catastrophic intraoperative hemorrhage.
Surgical treatment remains the primary curative option for RCC with IVCTT, and complete resection of both the primary tumor and the thrombus is essential for oncologic cure. The approach and complexity of surgery depends on the Mayo classification of thrombus level, with infrahepatic thrombus (levels I and II) being more surgically accessible than suprahepatic or intracardiac extension.
Robot-assisted radical nephrectomy (RARN) with IVC thrombectomy has been adopted at specialized centers as a minimally invasive alternative to open surgery for infrahepatic IVCTT, offering reduced blood loss, shorter hospital stay, and faster recovery while maintaining equivalent oncologic outcomes in selected patients.
The critical technical step in IVC thrombectomy is vascular occlusion before incising the IVC wall to remove the thrombus. Traditional technique requires separate clamping of the caudal IVC, the contralateral renal vein and artery, and the cephalic IVC, which leads to bilateral renal ischemia during the clamping period and potential postoperative renal dysfunction.
The oblique occlusion technique is a modified vascular clamping approach developed to control blood flow in the caudal IVC segment during thrombectomy while minimizing ischemia to the contralateral kidney. Rather than clamping the contralateral renal artery and vein separately, the technique uses a single oblique clamp or tourniquet that spans diagonally from the upper corner of one renal vein to the lower corner of the opposite renal vein.
For left RCC with IVCTT, the oblique block runs from the upper corner of the right renal vein to the lower corner of the left renal vein. This diagonal orientation occludes the caudal IVC and the proximal left renal vein while preserving the right renal vein outflow, allowing the right kidney to continue draining blood into the IVC above the clamp during the procedure.
Because the right renal vein remains patent and the right renal artery is not clamped in the oblique technique, the contralateral (right) kidney maintains blood supply and venous drainage throughout the clamping period. This contrasts with the traditional approach in which clamping the right renal vein without allowing drainage via tributaries causes congestion and ischemia in the right kidney.
Intraoperative ultrasound is essential to the oblique technique. It is used to confirm the absence of tumor thrombus in the contralateral renal vein and caudal IVC before applying the oblique clamp, ensuring the technique is oncologically safe and the clamp will not inadvertently embed within tumor tissue.
For left RCC with IVCTT, the procedure begins with the patient positioned in the right lateral decubitus position. A standard robotic port placement is established, and the peritoneum is incised along the Toldt line to mobilize the left colon. The left kidney is freed, the renal artery is clipped and divided, and the adrenal and gonadal veins are ligated. The left ureter is also divided at this stage.
The patient is then repositioned to the left lateral decubitus position, and additional robotic ports are placed on the right side. The hepatic and nephrocolic ligaments are divided to expose the right perirenal fascia and the IVC. The duodenum is pushed medially, and the IVC and both renal veins are fully dissociated. Intraoperative ultrasound is used at this point to confirm the proximal extent of the thrombus.
With the IVC and renal veins fully exposed, the oblique vessel tourniquet is positioned from the upper corner of the right renal vein to the lower corner of the left renal vein to occlude the caudal IVC segment. The cephalic IVC is then clamped with a separate vascular clamp above the proximal extent of the thrombus. The IVC wall is then incised at the angle between the left renal vein and the IVC, and the thrombus is removed.
After thrombus removal and inspection of the IVC wall for invasion, the IVC incision is continuously sutured with a vascular suture line and the tourniquet is released. The kidney and thrombus specimens are extracted through a median abdominal incision. Standard postoperative management includes early ambulation and monitoring for thromboembolic and renal function complications.
Twenty-one patients underwent RARN with IVC thrombectomy at the study institution from August 2019 to June 2020: 11 in the oblique group and 10 in the traditional group. Baseline characteristics including age, gender, BMI, tumor stage, and thrombus classification were similar between groups, with the notable exception of renal tumor size, which was smaller in the oblique group (5.8 cm versus 8.8 cm, p = 0.02).
Perioperative outcomes were comparable between the two groups, with no significant difference in operative time (149 versus 148 minutes, p = 0.86), IVC clamping time (18 versus 20 minutes, p = 0.41), or estimated blood loss (300 versus 500 mL, p = 0.51). These findings demonstrate that the oblique technique does not prolong the procedure or increase intraoperative blood loss compared to the established approach.
The key outcome distinguishing the two groups was serum creatinine at 3-month follow-up, which was significantly lower in the oblique group compared to the traditional group (95 versus 131 micromol/L, p = 0.03). No difference was found in creatinine at 1 week postoperatively (98 versus 120 micromol/L, p = 0.19), suggesting that the renal function benefit of the oblique technique emerges over the weeks following surgery rather than immediately.
During a median 16-month follow-up period, 2 patients in the oblique group experienced disease progression (one bone, one adrenal metastasis) compared to 3 in the traditional group (one liver, two lung metastases). This small difference in progression rates does not allow conclusions about oncologic equivalence but provides initial reassurance that the modified technique does not compromise tumor control.
The key physiological mechanism underlying the renal function benefit of the oblique technique is preservation of contralateral renal venous drainage. In the traditional technique, clamping the right renal vein while the right renal artery remains open causes venous congestion in the right kidney, leading to ischemic injury during the clamping period even when the clamping time is within the generally accepted 30-minute safe window.
By applying the oblique clamp diagonally, the right renal vein orifice into the IVC above the clamp remains open, allowing blood from the right kidney to drain despite the clamped caudal IVC segment. The right renal artery is not clamped in this technique, so blood flow to the contralateral kidney is maintained throughout, and venous outflow is preserved through the patent renal vein. This avoids the congestion-ischemia cycle entirely.
The technique is anatomically specific to left RCC cases with infrahepatic IVCTT, where the left renal vein must be controlled and the right renal vein orifice lies above the oblique occlusion zone. For right RCC cases, the oblique clamp runs from the upper corner of the left renal vein to the lower corner of the right renal vein, preserving left renal drainage instead. The left renal artery is not clamped because the left renal vein has several collateral tributaries (gonadal, adrenal, and lumbar veins) that allow venous return despite left renal vein clamping.
Patient selection is critical for safe application of the oblique technique. It requires preoperative imaging confirmation of no tumor thrombus in the contralateral renal vein or caudal IVC, and intraoperative ultrasound confirmation. Cases with filled-type thrombus obstructing the contralateral renal vein opening or with bland thrombus extension distally are not suitable candidates.
This study introduces the IVC oblique occlusion technique as a safe and effective modification of standard vascular control in robot-assisted radical nephrectomy with IVC thrombectomy, achieving equivalent perioperative outcomes while significantly improving 3-month renal function compared to the traditional approach.
The 3-month creatinine benefit (95 versus 131 micromol/L) is clinically meaningful for patients who already face a baseline risk of renal function compromise from the loss of the primary tumor-bearing kidney. Preserving contralateral renal function reduces the risk of dialysis dependence and improves long-term quality of life in this patient population.
The step-by-step description of the technique, including patient positioning, port placement, intraoperative ultrasound use, and management of potential bleeding emergencies, provides a practical guide for urological surgeons at centers adopting robot-assisted approaches to this complex operation.
Larger multicenter prospective studies with longer follow-up are needed to confirm the renal function benefit, fully assess oncologic equivalence, and establish formal patient selection criteria that identify candidates most likely to benefit from the oblique technique over the traditional approach.